These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 425410)

  • 1. [Rosette formation phenomenon in the presence of tumor antigen].
    Saraeva ZM; Tereshchenko IP
    Vopr Onkol; 1979; 25(2):66-7. PubMed ID: 425410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigens associated with human breast carcinoma].
    Kriukova IN; Vasilevskaia LN
    Vopr Onkol; 1975; 21(2):52-6. PubMed ID: 805495
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed hypersensitivity reaction in malignant melanoma].
    Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
    Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytofluorometric detection of tumor-specific rosette-forming cells in patients with squamous cell carcinoma of the head and neck.
    Tong AW; Vanderbark AA; Kraybill W; Vetto RM; Burger DR
    Cancer Res; 1982 Jul; 42(7):2949-55. PubMed ID: 6177400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extension of the rosette test in the estimation of TAA-binding cells in breast cancer and mastopathy patients].
    Sauer H; Preusse C; Gläser A; Hädge D; Kraus I; Ambrosius H
    Allerg Immunol (Leipz); 1982; 28(3):177-86. PubMed ID: 6183964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of discrete plasmapheresis in severe forms of laryngeal papillomatosis in children].
    Shuster MA; Ol'shanskiĭ AIa; Selin VN; Davatradova GM; Ashurov ZM
    Vestn Otorinolaringol; 1992; (1):27-9. PubMed ID: 1589938
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of the study of neoplastic antigens].
    Lisiewicz J; Moszczyński P
    Pol Tyg Lek; 1984 Feb; 39(6):201-4. PubMed ID: 6204325
    [No Abstract]   [Full Text] [Related]  

  • 11. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of safe-intensity laser irradiation on the immune system].
    Kupin VI; Sorokin AM; Ivanov AV; Lapteva RM; Polevaia EB
    Sov Med; 1985; (7):8-12. PubMed ID: 3877990
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
    Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [State of the stroma in melanoma in patients with different delayed hypersensitivity reaction to neoplasm antigen].
    Lavnikova GA; Voronina EA; Babakova SV
    Vopr Onkol; 1978; 24(11):24-30. PubMed ID: 741696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of a TAA-specific sensitization in patients with metastatic breast cancer following breast removal and upper and lower half-body irradiation].
    Brock A; Standke E; Sauer H; Ambrosius H
    Radiobiol Radiother (Berl); 1987; 28(3):355-62. PubMed ID: 3659321
    [No Abstract]   [Full Text] [Related]  

  • 16. MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
    Dubovsky JA; Albertini MR; McNeel DG
    J Immunother; 2007 Oct; 30(7):675-83. PubMed ID: 17893560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
    Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
    Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
    [No Abstract]   [Full Text] [Related]  

  • 18. Self-recognition and tumor response to immunotherapy.
    Ernstoff MS
    J Clin Oncol; 2005 Sep; 23(25):5875-7. PubMed ID: 16087939
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivity of serum-armed xenogeneic macrophages to breast cancer antigens.
    Harris LF; Miller LL; Hickok DF
    Cancer Res; 1982 Dec; 42(12):4985-90. PubMed ID: 7139603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic T-cell immune response against melanoma antigens].
    Ayyoub M
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.